Clinical Trial Update: S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating combination chemotherapy with monoclonal antibody therapy in newly diagnosed Non-Hodgkin's lymphoma; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Chemotherapy (unspecified)
• Monoclonal antibody therapy (unspecified)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2013-02-26